Publication:
Polypharmacy, potentially inappropriate prescribing and medication complexity in Turkish older patients in the community pharmacy setting

dc.contributor.authorOKUYAN, BETÜL
dc.contributor.authorSANCAR, MESUT
dc.contributor.authorsSayin, Zeynep; Sancar, Mesut; Ozen, Yasin; Okuyan, Betul
dc.date.accessioned2022-03-12T22:39:54Z
dc.date.accessioned2026-01-10T19:23:37Z
dc.date.available2022-03-12T22:39:54Z
dc.description.abstractObjective This study aimed to evaluate polypharmacy, potentially inappropriate prescribing (PIP) and medication complexity in Turkish older patients in the community pharmacy setting and to determine the factors associated with PIP. Methods This descriptive cross-sectional study was conducted in the community pharmacy setting in Istanbul. Older patients (>= 65 years old) who chronically used at least one medication and visited the community pharmacy for any reason in the past 4 months were invited in this study. PIP was determined by using the Ghent Older People's Prescriptions Community Pharmacy Screening (GheOP(3)S)-tool. The Turkish version of the Medication Regimen Complexity Index (MRCI) was used to determine medication complexity. Results Polypharmacy (defined as the concurrent use of five or more medications) was found in 69.0% of 158 patients. A total of 398 PIPs were detected and 83.5% (n = 132) of older patients had at least one PIP. The median (IQR) MRCI score was 12.5 (7.0-19.6). The factors associated with having >= 2 PIP were advanced age (>= 75 years old) (OR = 2.87, 95% CI 1.41-5.81;p< 0.05), higher number of chronic diseases (when >= 3, OR = 8.51, 95% CI 3.66-19.76;p< 0.05), receiving polypharmacy (OR = 8.92, 95% CI 4.09-19.46;p< 0.05), and higher MRCI scores (when MRCI >= 12.5, OR = 4.40, 95% CI 2.22-8.71;p< 0.05). Conclusion More than half of the Turkish older patients had polypharmacy and the rate of PIP was high. A higher number of PIP was associated with advanced age, higher number of chronic diseases, polypharmacy, and more complex medication regimens.
dc.identifier.doi10.1080/17843286.2020.1829251
dc.identifier.eissn2295-3337
dc.identifier.issn1784-3286
dc.identifier.pubmed33031002
dc.identifier.urihttps://hdl.handle.net/11424/235880
dc.identifier.wosWOS:000576778600001
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS LTD
dc.relation.ispartofACTA CLINICA BELGICA
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPotentially inappropriate prescribing
dc.subjectpotentially prescribing omission
dc.subjectpolypharmacy
dc.subjectmedication complexity
dc.subjectpharmacist
dc.subjectCOST OUTCOMES
dc.subjectPEOPLE
dc.subjectVALIDATION
dc.subjectQUALITY
dc.subjectADULTS
dc.titlePolypharmacy, potentially inappropriate prescribing and medication complexity in Turkish older patients in the community pharmacy setting
dc.typearticle
dspace.entity.typePublication
oaire.citation.titleACTA CLINICA BELGICA

Files